Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1638, 2008-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Blood glucose self monitoring not economical in T2DM
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 553, 2008-01 ,pp. :
Access to resources
Recommend
Self-monitoring for T2DM in Canada: what do the models say?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 642, 2011-01 ,pp. :
Self-monitoring of blood glucose not worth it in Canada
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 597, 2010-01 ,pp. :
Current and Future Treatment Directions in T2DM
Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. :
Pioglitazone improves measures of T2DM and dyslipidaemia
Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. :